Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS)
CNY 21.63
(-0.18%)
CNY 21.63
(-0.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.01 Billion | 825.49 Million | 928.8 Million | 655 Million | 1.17 Billion | 1.14 Billion |
| Cost of Revenue | 223.04 Million | 201.2 Million | 210.02 Million | 102.28 Million | 145.96 Million | 118.28 Million |
| Gross Profit | 790.99 Million | 624.29 Million | 718.78 Million | 552.71 Million | 1.03 Billion | 1.02 Billion |
| Operating Expenses | 545.28 Million | 619.24 Million | 792.09 Million | 770.59 Million | 833.09 Million | 638.73 Million |
| Selling, General and Administrative Expenses | 297.16 Million | 272.43 Million | 298.55 Million | 399.46 Million | 512.94 Million | 396.48 Million |
| Research and Development Expenses | 249.18 Million | 313.28 Million | 455.09 Million | 340.24 Million | 278.88 Million | 198.71 Million |
| Other Expenses | 1.06 Million | 33.52 Million | 38.45 Million | 30.88 Million | 41.26 Million | -10.11 Million |
| Cost and Expenses | 695.82 Million | 820.44 Million | 1 Billion | 872.88 Million | 979.06 Million | 757.02 Million |
| Operating Income | 318.21 Million | 4.86 Million | -83.29 Million | -217.88 Million | 171.45 Million | 421.45 Million |
| Interest Expense | 1.59 Million | 1.31 Million | 171.96 Thousand | 122.16 Thousand | 95.78 Thousand | 1.6 Million |
| Income Tax Expense | 27.27 Million | -16.47 Million | -51.69 Million | -46.59 Million | 19.18 Million | 53.36 Million |
| Earnings before Tax | 310.63 Million | 28.95 Million | -53.38 Million | -282.4 Million | 229.23 Million | 411.33 Million |
| Net Income | 294.61 Million | 49.29 Million | -1.69 Million | -235.81 Million | 229.29 Million | 369.66 Million |
| Earnings Per Share Basic | 0.48 | 0.08 | -0.00 | -0.38 | 0.37 | 0.72 |
| Earnings Per Share Diluted | 0.48 | 0.08 | -0.00 | -0.38 | 0.37 | 0.72 |
| Weighted Average Shares Outstanding | 613.78 Million | 616.78 Million | 616.21 Million | 616.21 Million | 616.21 Million | 513.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 613.78 Million | 616.78 Million | 616.21 Million | 616.21 Million | 616.21 Million | 513.41 Million |
| Gross Margin | 0.78 | 0.76 | 0.77 | 0.84 | 0.88 | 0.90 |
| EBIT Margin | 0.42 | 0.15 | 0.06 | -0.15 | 0.26 | 0.44 |
| Profit Margin | 0.29 | 0.06 | -0.00 | -0.36 | 0.19 | 0.32 |
| EBITDA | 424.7 Million | 168.16 Million | 62.14 Million | -97.33 Million | 356.82 Million | 531.47 Million |
| Earnings Before Tax Margin | 0.31 | 0.01 | -0.09 | -0.33 | 0.15 | 0.37 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 342.78 Million | 327.27 Million | 264.75 Million | 280.89 Million | 1 Billion | 252.79 Million |
| Cost of Revenue | 72.18 Million | 108.78 Million | 61.18 Million | 60.03 Million | 268.14 Million | 49.09 Million |
| Gross Profit | 270.6 Million | 218.48 Million | 203.57 Million | 220.85 Million | 736.51 Million | 203.69 Million |
| Operating Expenses | 170.99 Million | 181.78 Million | 121.92 Million | 164.88 Million | 545.28 Million | 134.41 Million |
| Selling, General and Administrative Expenses | 149.09 Million | 95.52 Million | 68.69 Million | 64.84 Million | - | 109.8 Million |
| Research and Development Expenses | 106.55 Million | 86.22 Million | 53.16 Million | 101.55 Million | - | 49.94 Million |
| Other Expenses | -84.65 Million | -21.5 Thousand | -72 Thousand | 1.51 Million | 1.06 Million | -3.45 Million |
| Cost and Expenses | 243.17 Million | 290.56 Million | 183.1 Million | 224.92 Million | 813.43 Million | 183.51 Million |
| Operating Income | 112 Million | 36.7 Million | 81.64 Million | 55.97 Million | 191.22 Million | 79.19 Million |
| Interest Expense | 283.7 Thousand | 305.3 Thousand | 302.8 Thousand | 306.29 Thousand | 1.59 Million | 313.05 Thousand |
| Income Tax Expense | 7.99 Million | 2.91 Million | 11.1 Million | 12.91 Million | 27.27 Million | 9.99 Million |
| Earnings before Tax | 106.38 Million | 48.34 Million | 103.3 Million | 144.95 Million | 327.03 Million | 75.74 Million |
| Net Income | 103.53 Million | 38.39 Million | 91.11 Million | 130.69 Million | 294.61 Million | 69.16 Million |
| Earnings Per Share Basic | 0.17 | 0.06 | 0.15 | 0.21 | - | 0.11 |
| Earnings Per Share Diluted | 0.17 | 0.06 | 0.15 | 0.21 | - | 0.11 |
| Weighted Average Shares Outstanding | 616.78 Million | 616.78 Million | 616.78 Million | 616.78 Million | 616.78 Million | 616.78 Million |
| Weighted Average Shares Outstanding (Diluted) | 616.78 Million | 616.78 Million | 616.78 Million | 616.78 Million | 616.78 Million | 616.78 Million |
| Gross Margin | 0.79 | 0.67 | 0.77 | 0.79 | 0.73 | 0.81 |
| EBIT Margin | 0.31 | 0.21 | 0.36 | 0.27 | - | 0.28 |
| Profit Margin | 0.30 | 0.12 | 0.34 | 0.47 | 0.29 | 0.27 |
| EBITDA | 106.66 Million | 69.2 Million | 95.22 Million | 74.68 Million | - | 71.88 Million |
| Earnings Before Tax Margin | 0.33 | 0.11 | 0.31 | 0.20 | 0.19 | 0.31 |
0043
SPLPETRO
ENADF
CYIENTDLM
LVH
OCINF